Insight Molecular Diagnostics (IMDX) Receivables - Net (2020 - 2025)
Insight Molecular Diagnostics' Receivables - Net history spans 6 years, with the latest figure at $258000.0 for Q3 2025.
- For Q3 2025, Receivables - Net rose 23.44% year-over-year to $258000.0; the TTM value through Sep 2025 reached $258000.0, up 23.44%, while the annual FY2024 figure was $1.6 million, 233.26% up from the prior year.
- Receivables - Net for Q3 2025 was $258000.0 at Insight Molecular Diagnostics, down from $512000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $3.5 million in Q1 2025 and bottomed at $85000.0 in Q2 2024.
- The 5-year median for Receivables - Net is $703000.0 (2021), against an average of $1.1 million.
- The largest annual shift saw Receivables - Net soared 5307.69% in 2021 before it crashed 85.67% in 2024.
- A 5-year view of Receivables - Net shows it stood at $1.4 million in 2021, then fell by 2.57% to $1.4 million in 2022, then plummeted by 65.43% to $484000.0 in 2023, then skyrocketed by 233.26% to $1.6 million in 2024, then tumbled by 84.0% to $258000.0 in 2025.
- Per Business Quant, the three most recent readings for IMDX's Receivables - Net are $258000.0 (Q3 2025), $512000.0 (Q2 2025), and $3.5 million (Q1 2025).